Cargando…

Interventional therapy for human breast cancer in nude mice with (131)I gelatin microspheres ((131)I-GMSs) following intratumoral injection

INTRODUCTION: The aim of this study was to investigate the effects of (131)I gelatin microspheres ((131)I-GMS) on human breast cancer cells (MCF-7) in nude mice and the biodistribution of (131)I-GMSs following intratumoral injections. METHODS: A total of 20 tumor-bearing mice were divided into a tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chuan-Chao, Chi, Jun-Lin, Ma, Yu, Li, Jian-Hong, Xia, Chuan-Qin, Li, Lin, Chen, Zhuo, Chen, Xiao-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083354/ https://www.ncbi.nlm.nih.gov/pubmed/24958442 http://dx.doi.org/10.1186/1748-717X-9-144

Ejemplares similares

(131)I–Tositumomab in lymphoma
por: Cheung, M.C., et al.
Publicado: (2009)

Radioiodination and Purification of [(131)I]β-CIT and [(131)I]FP-CIT with an Automated Radiosynthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2022)

Apoptosis gene reprograming of human peripheral blood mononuclear cells induced by radioiodine-131 ((131)I) irradiation
por: Li, Jian-Fang, et al.
Publicado: (2019)

Radioimmunotherapy for Pancreatic Carcinoma Using (131)I‐Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice
por: Inui, Akimasa, et al.
Publicado: (1996)

Nodular hepatocellular carcinoma--treatment with intraarterial injection of I-131 Lipiodol.
por: Yoo, H. S., et al.
Publicado: (1990)

Treatment failure in hyperthyroid cats after radioiodine (I‐131) injection
por: Mullowney, Deirdre, et al.
Publicado: (2021)

Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice
por: Chen, Jing, et al.
Publicado: (2014)

(131)I-Labeled Copper Sulfide-Loaded Microspheres to Treat Hepatic Tumors via Hepatic Artery Embolization
por: Liu, Qiufang, et al.
Publicado: (2018)

(131)I-Caerin 1.1 and (131)I-Caerin 1.9 for the treatment of non-small-cell lung cancer
por: Liu, Na, et al.
Publicado: (2022)

(131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients
por: Garaventa, A, et al.
Publicado: (1999)

Therapy of cervical cancer using (131)I-labeled nanoparticles
por: Li, Wei, et al.
Publicado: (2018)

I-131 uptake in fat necrosis of the breast
por: Itani, Malak, et al.
Publicado: (2016)

Thyroid Remnant Estimation by Diagnostic Dose (131) I Scintigraphy or (99m) T c O (4) (−) Scintigraphy after Thyroidectomy: A Comparison with Therapeutic Dose (131) I Imaging
por: Liu, Guanghui, et al.
Publicado: (2016)

Toxicity of upfront (131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis
por: Bleeker, Gitta, et al.
Publicado: (2013)

The influence of thionamides on intra-thyroidal uptake of (131)I during radioiodine-131 treatment of Graves’ disease
por: Happel, Christian, et al.
Publicado: (2023)

Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity.
por: Vaidyanathan, G., et al.
Publicado: (1996)

Development of [(131)I]I-EOE-TPZ and [(131)I]I-EOE-TPZMO: Novel Tirapazamine (TPZ)-Based Radioiodinated Pharmaceuticals for Application in Theranostic Management of Hypoxia
por: Elsaidi, Hassan, et al.
Publicado: (2019)

Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas.
por: Steffens, M. G., et al.
Publicado: (1998)

Thyroid dose assessments due to inhalation of (131)I for nuclear medicine workers
por: Liu, Gang, et al.
Publicado: (2022)

Induction of Leukaemia by (131)I Treatment of Thyroid Carcinoma
por: Brincker, H., et al.
Publicado: (1973)

Biodistribution of (131)I in mice is influenced by circadian variations
por: Andersson, Charlotte K., et al.
Publicado: (2020)

MON-437 False Positive I-131 Uptake
por: Yadav, Pavan Rajendra, et al.
Publicado: (2020)

Anti-metastatic effect of (131)I-labeled Buthus martensii Karsch chlorotoxin in gliomas
por: Wu, Shan, et al.
Publicado: (2018)

Dosimetric analysis of (123)I, (125)I and (131)I in thyroid follicle models
por: Josefsson, Anders, et al.
Publicado: (2014)

Predictive factors for the outcomes of Graves’ disease patients with radioactive iodine ((131)I) treatment
por: Xing, Yu-Zhuo, et al.
Publicado: (2020)

The use of 131I-MIBG in the imaging of metastatic carcinoid tumours.
por: Jodrell, D. I., et al.
Publicado: (1988)

Sequelae and survivorship in patients treated with (131)I-MIBG therapy
por: Sze, W C C, et al.
Publicado: (2013)

Unexpected Uptake by the Gallbladder in Post-Ablative I-131 Scan
por: Ünal, Kemal, et al.
Publicado: (2015)

Inguinal Endometriosis Visualized on I-131 Whole Body Scan
por: Çayır, Derya, et al.
Publicado: (2018)

Targeted radiotherapy of pigmented melanoma with (131)I-5-IPN
por: Xu, Xiaodong, et al.
Publicado: (2018)

Transcriptional response to (131)I exposure of rat thyroid gland
por: Rudqvist, Nils, et al.
Publicado: (2017)

Disorders of Dental Hard Tissues Induced by Radioiodine-131 (I-131) Therapy Used in Differentiated Thyroid Cancer: An In Vitro Study
por: Mester, Alexandru, et al.
Publicado: (2020)

Improved Quantification of (18)F-FDG PET during (131)I-Rituximab Therapy on Mouse Lymphoma Models after (131)I Prompt Emission Correction
por: Lee, Young Sub, et al.
Publicado: (2019)

Gut microbiota is associated with response to (131)I therapy in patients with papillary thyroid carcinoma
por: Zheng, Lei, et al.
Publicado: (2022)

A case report of (131)I therapy for Graves’ disease patient with hemiagenesis
por: Liu, Xuehui, et al.
Publicado: (2019)

Radioimmunotherapy study of (131)I-labeled Atezolizumab in preclinical models of colorectal cancer
por: Zhang, Linhan, et al.
Publicado: (2022)

An Experimental Study on (131)I-CHIBA-1001: A Radioligand for α7 Nicotinic Acetylcholine Receptors
por: Yin, Lei, et al.
Publicado: (2013)

Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice
por: Lin, Ruoting, et al.
Publicado: (2021)

Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of (131)I during radioiodine therapy of Graves’ disease
por: Happel, C., et al.
Publicado: (2021)

Global Hotspots and Prospects of I-131 Therapy in Thyroid Carcinoma via Bibliometric Analysis
por: Lin, Shang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dtak5f0qt2ugrv94en0c9q6mj0